11/18
10:03 am
nari
Inside a $400 billion bet on the brain-computer interface revolution [Yahoo! Finance Canada]
Low
Report
Inside a $400 billion bet on the brain-computer interface revolution [Yahoo! Finance Canada]
11/18
10:02 am
nari
Inside a $400 billion bet on the brain-computer interface revolution [Yahoo! Finance]
Low
Report
Inside a $400 billion bet on the brain-computer interface revolution [Yahoo! Finance]
11/7
09:08 am
nari
Is Inari Medical (NARI) Trading at an Attractive Valuation? [Yahoo! Finance]
Low
Report
Is Inari Medical (NARI) Trading at an Attractive Valuation? [Yahoo! Finance]
11/6
04:05 pm
nari
Inari Medical to Participate in the Jefferies London Healthcare Conference
Low
Report
Inari Medical to Participate in the Jefferies London Healthcare Conference
10/29
01:23 pm
nari
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Truist Financial Co. from $46.00 to $50.00. They now have a "hold" rating on the stock.
Medium
Report
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Truist Financial Co. from $46.00 to $50.00. They now have a "hold" rating on the stock.
10/29
11:56 am
nari
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
Low
Report
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
10/29
08:16 am
nari
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Canaccord Genuity Group Inc. from $71.00 to $74.00. They now have a "buy" rating on the stock.
Medium
Report
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Canaccord Genuity Group Inc. from $71.00 to $74.00. They now have a "buy" rating on the stock.
10/29
08:00 am
nari
Inari Medical, Inc. (NASDAQ: NARI) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Medium
Report
Inari Medical, Inc. (NASDAQ: NARI) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
10/29
08:00 am
nari
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Piper Sandler from $50.00 to $52.00. They now have a "neutral" rating on the stock.
Medium
Report
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Piper Sandler from $50.00 to $52.00. They now have a "neutral" rating on the stock.
10/29
08:00 am
nari
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Robert W. Baird from $66.00 to $67.00. They now have an "outperform" rating on the stock.
Medium
Report
Inari Medical, Inc. (NASDAQ: NARI) had its price target raised by analysts at Robert W. Baird from $66.00 to $67.00. They now have an "outperform" rating on the stock.
10/28
04:05 pm
nari
Inari Medical Reports Third Quarter 2024 Financial Results
High
Report
Inari Medical Reports Third Quarter 2024 Financial Results
10/28
03:02 am
nari
Inari Medical: A $4 Billion Opportunity Is Wide Open [Seeking Alpha]
Low
Report
Inari Medical: A $4 Billion Opportunity Is Wide Open [Seeking Alpha]
10/21
01:00 pm
nari
Okami Medical Announces Closing Of $32.5M Financing
Low
Report
Okami Medical Announces Closing Of $32.5M Financing
10/15
02:00 pm
nari
NBCA Announces Endorsement of Inari Medical DEFIANCE Trial [Yahoo! Finance]
Low
Report
NBCA Announces Endorsement of Inari Medical DEFIANCE Trial [Yahoo! Finance]
10/15
08:00 am
nari
Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial
Medium
Report
Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial
10/14
10:35 am
nari
Inari Medical, Inc. (NASDAQ: NARI) had its price target lowered by analysts at Truist Financial Co. from $55.00 to $46.00. They now have a "hold" rating on the stock.
Medium
Report
Inari Medical, Inc. (NASDAQ: NARI) had its price target lowered by analysts at Truist Financial Co. from $55.00 to $46.00. They now have a "hold" rating on the stock.
10/9
08:33 am
nari
Inari Medical, Inc. (NASDAQ: NARI) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
Inari Medical, Inc. (NASDAQ: NARI) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
10/7
04:06 pm
nari
Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation
Medium
Report
Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation
10/7
04:05 pm
nari
Inari Medical to Announce Third Quarter 2024 Financial Results
Medium
Report
Inari Medical to Announce Third Quarter 2024 Financial Results
9/19
08:00 am
nari
Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Long-Term NARI Shareholders to Contact the Firm
Low
Report
Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Long-Term NARI Shareholders to Contact the Firm
9/17
05:06 pm
nari
Inari Medical, Inc. (NASDAQ: NARI) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating and a $50.00 price target on the stock.
Low
Report
Inari Medical, Inc. (NASDAQ: NARI) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating and a $50.00 price target on the stock.
9/17
08:00 am
nari
Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Investors to Contact the Firm
Medium
Report
Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Investors to Contact the Firm
9/13
10:11 am
nari
Reasons to Retain Inari Medical Stock in Your Portfolio for Now [Yahoo! Finance]
Low
Report
Reasons to Retain Inari Medical Stock in Your Portfolio for Now [Yahoo! Finance]
9/4
05:38 am
nari
Inari Medical, Inc. (NASDAQ: NARI) was upgraded by analysts at Leerink Partnrs to a "hold" rating.
Low
Report
Inari Medical, Inc. (NASDAQ: NARI) was upgraded by analysts at Leerink Partnrs to a "hold" rating.
9/3
08:04 am
nari
Inari Medical, Inc. (NASDAQ: NARI) is now covered by analysts at Leerink Partners. They set a "market perform" rating and a $47.00 price target on the stock.
Low
Report
Inari Medical, Inc. (NASDAQ: NARI) is now covered by analysts at Leerink Partners. They set a "market perform" rating and a $47.00 price target on the stock.